Stock To Watch: China Biologic Products, Inc. (NASDAQ:CBPO)


The leading market experts have placed a mean price target of $146.14 on China Biologic Products, Inc. (NASDAQ:CBPO) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $1.11 a share for the upcoming quarter and $4.29 for the current fiscal. Technical View The technical analysis of China Biologic Products, Inc. plainly substantiates that the 50-day moving average of China Biologic Products, Inc. is $110.63, and stock is hovering 8.75 or +7.91% distant from $110.63. It is noted that the 200-day MA is $115.63, and China Biologic Products, Inc. stock is $3.75 or +3.24% off from this point. China Biologic Products, Inc. (NASDAQ:CBPO) 52-week high is $144.29 and the 52-week low is $80.60. This explains if the stock moves $-24.91, it will post a 52-week high. In event of $+48.11% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of China Biologic Products, Inc., shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, China Biologic Products, Inc. (NASDAQ:CBPO) ratio came in at 35.71. The stock last ended the trading session at $119.38 and registered a market cap of $3.17B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. China Biologic Products, Inc. (NASDAQ:CBPO) PEG ratio is at 1.46.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 17 times, 1 visits today)